Conditions: Binge Eating Disorder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 22
Healthy volunteers: no

Brief summary:
This study will test the effectiveness of the combination of Naltrexone and Bupropion relative to placebo for reducing binge eating in persons with obesity and binge eating disorder.

Detailed description:

Arms:
arm 1: 50 mg naltrexone and 300 mg bupropion per day for 3 months arm 2: Daily placebo medication for 3 months

Interventions: intervention 1: Naltrexone and bupropion combination intervention 2: Pill Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: